IDXX Articles, IDEXX Laboratories Inc. - From 11/20/23

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 14.19% on an annualized basis producing an average annual re...

IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q3 FY23 sales of $915.53 million, missing the consensus of $926.76 million. Adjusted EPS w...

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 20 years by 4.28% on an annualized basis producing an average annual ret...

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 11.5% on an annualized basis producing an average annual ret...

Stifel analyst Jonathan D. Block reiterated a Hold rating on IDEXX Laboratories, Inc. (NASDAQ: IDXX), lowering the price target...

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 15 years by 10.94% on an annualized basis producing an average annual re...

IDEXX Laboratories (NASDAQ:IDXX) has outperformed the market over the past 10 years by 16.16% on an annualized basis producing an average annual re...